- Home
- IPW vs CCEL Comparison
IPW vs CCEL Comparison
Compare IPW & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- CCEL
- Stock Information
- Founded
- IPW 2018
- CCEL 1989
- Country
- IPW United States
- CCEL United States
- Employees
- IPW N/A
- CCEL N/A
- Industry
- IPW Catalog/Specialty Distribution
- CCEL Managed Health Care
- Sector
- IPW Consumer Discretionary
- CCEL Health Care
- Exchange
- IPW Nasdaq
- CCEL Nasdaq
- Market Cap
- IPW 21.7M
- CCEL 56.8M
- IPO Year
- IPW 2021
- CCEL 1997
- Fundamental
- Price
- IPW $0.54
- CCEL $6.40
- Analyst Decision
- IPW Strong Buy
- CCEL Strong Buy
- Analyst Count
- IPW 1
- CCEL 1
- Target Price
- IPW $2.75
- CCEL $8.50
- AVG Volume (30 Days)
- IPW 48.5K
- CCEL 15.7K
- Earning Date
- IPW 02-13-2025
- CCEL 04-14-2025
- Dividend Yield
- IPW N/A
- CCEL 3.91%
- EPS Growth
- IPW N/A
- CCEL N/A
- EPS
- IPW N/A
- CCEL 0.05
- Revenue
- IPW $80,844,081.00
- CCEL $31,986,106.00
- Revenue This Year
- IPW $8.31
- CCEL $2.21
- Revenue Next Year
- IPW $77.15
- CCEL $0.98
- P/E Ratio
- IPW N/A
- CCEL $129.21
- Revenue Growth
- IPW N/A
- CCEL 2.05
- 52 Week Low
- IPW $0.40
- CCEL $5.35
- 52 Week High
- IPW $3.65
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- IPW 30.82
- CCEL 38.03
- Support Level
- IPW $0.41
- CCEL $6.39
- Resistance Level
- IPW $0.64
- CCEL $7.70
- Average True Range (ATR)
- IPW 0.07
- CCEL 0.61
- MACD
- IPW -0.01
- CCEL -0.11
- Stochastic Oscillator
- IPW 30.31
- CCEL 10.64
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.